Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million ≈ $5.88 Million USD) by net assets (CN¥8.71 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002019 equity financing ratio to measure how much of total assets are equity-financed.

Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002019 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Fleury S.A.
SA:FLRY3
0.050x
SUEDZUCKER UNSP.ADR 1/2
F:SZU1
-0.001x
Worthington Steel Inc
NYSE:WS
0.047x
Ducommun Incorporated
NYSE:DCO
0.028x
Quantum Computing Inc
NASDAQ:QUBT
-0.007x
Anyuan Coal Industry Group Co Ltd
SHG:600397
-0.011x
AOZORA BANK LTD ADR/20
F:AON0
N/A
Dom Development S.A.
WAR:DOM
-0.038x

Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Yifan Xinfu Pharmaceutical Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.71 Billion
≈ $1.27 Billion
CN¥458.37 Million
≈ $67.07 Million
0.053x -30.80%
2024-12-31 CN¥8.43 Billion
≈ $1.23 Billion
CN¥640.73 Million
≈ $93.76 Million
0.076x +80.06%
2023-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥348.58 Million
≈ $51.01 Million
0.042x -18.18%
2022-12-31 CN¥9.15 Billion
≈ $1.34 Billion
CN¥472.07 Million
≈ $69.08 Million
0.052x +50.34%
2021-12-31 CN¥8.78 Billion
≈ $1.28 Billion
CN¥301.23 Million
≈ $44.08 Million
0.034x -73.01%
2020-12-31 CN¥8.72 Billion
≈ $1.28 Billion
CN¥1.11 Billion
≈ $162.21 Million
0.127x +6.13%
2019-12-31 CN¥7.82 Billion
≈ $1.14 Billion
CN¥937.24 Million
≈ $137.15 Million
0.120x -29.51%
2018-12-31 CN¥6.89 Billion
≈ $1.01 Billion
CN¥1.17 Billion
≈ $171.34 Million
0.170x +1.79%
2017-12-31 CN¥6.78 Billion
≈ $992.46 Million
CN¥1.13 Billion
≈ $165.75 Million
0.167x -23.88%
2016-12-31 CN¥3.90 Billion
≈ $570.77 Million
CN¥855.85 Million
≈ $125.24 Million
0.219x +57.24%
2015-12-31 CN¥2.88 Billion
≈ $421.52 Million
CN¥401.96 Million
≈ $58.82 Million
0.140x +154.00%
2014-12-31 CN¥2.54 Billion
≈ $372.19 Million
CN¥139.74 Million
≈ $20.45 Million
0.055x -38.38%
2013-12-31 CN¥384.95 Million
≈ $56.33 Million
CN¥34.32 Million
≈ $5.02 Million
0.089x +43.45%
2012-12-31 CN¥480.81 Million
≈ $70.36 Million
CN¥29.88 Million
≈ $4.37 Million
0.062x +155.24%
2011-12-31 CN¥469.52 Million
≈ $68.71 Million
CN¥-52.82 Million
≈ $-7.73 Million
-0.113x -134.03%
2010-12-31 CN¥703.64 Million
≈ $102.96 Million
CN¥-33.82 Million
≈ $-4.95 Million
-0.048x -174.89%
2009-12-31 CN¥913.15 Million
≈ $133.62 Million
CN¥58.61 Million
≈ $8.58 Million
0.064x -56.02%
2008-12-31 CN¥570.87 Million
≈ $83.54 Million
CN¥83.31 Million
≈ $12.19 Million
0.146x -67.81%
2007-12-31 CN¥548.55 Million
≈ $80.27 Million
CN¥248.71 Million
≈ $36.39 Million
0.453x +351.02%
2006-12-31 CN¥324.46 Million
≈ $47.48 Million
CN¥32.62 Million
≈ $4.77 Million
0.101x +33.73%
2005-12-31 CN¥320.93 Million
≈ $46.96 Million
CN¥24.12 Million
≈ $3.53 Million
0.075x -30.63%
2004-12-31 CN¥309.98 Million
≈ $45.36 Million
CN¥33.59 Million
≈ $4.91 Million
0.108x -19.25%
2003-12-31 CN¥94.31 Million
≈ $13.80 Million
CN¥12.65 Million
≈ $1.85 Million
0.134x --

About Yifan Xinfu Pharmaceutical Co Ltd

SHE:002019 China Drug Manufacturers - General
Market Cap
$1.83 Billion
CN¥12.49 Billion CNY
Market Cap Rank
#6382 Global
#1262 in China
Share Price
CN¥10.27
Change (1 day)
+0.39%
52-Week Range
CN¥9.35 - CN¥16.29
All Time High
CN¥32.51
About

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more